| A microRNA expression signature of human solid tumors defines cancer gene targets S Volinia, GA Calin, CG Liu, S Ambs, A Cimmino, F Petrocca, R Visone, ... Proceedings of the National Academy of Sciences 103 (7), 2257-2261, 2006 | 7356 | 2006 |
| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3355 | 2016 |
| Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 2728 | 2015 |
| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012 | 2240 | 2012 |
| TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system G Rindi, G Klöppel, XXH Alhman, M Caplin, A Couvelard, WW De Herder, ... Virchows Archiv 449, 395-401, 2006 | 1700 | 2006 |
| TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system G Rindi, G Klöppel, A Couvelard, P Komminoth, M Körner, JM Lopes, ... Virchows Archiv 451, 757-762, 2007 | 1146 | 2007 |
| A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal G Rindi, DS Klimstra, B Abedi-Ardekani, SL Asa, FT Bosman, E Brambilla, ... Modern Pathology 31 (12), 1770-1786, 2018 | 1035 | 2018 |
| MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior C Roldo, E Missiaglia, JP Hagan, M Falconi, P Capelli, S Bersani, ... Journal of Clinical Oncology 24 (29), 4677-4684, 2006 | 1019 | 2006 |
| Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group F Mosele, J Remon, J Mateo, CB Westphalen, F Barlesi, MP Lolkema, ... Annals of Oncology 31 (11), 1491-1505, 2020 | 995 | 2020 |
| Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017 | 905 | 2017 |
| ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a … C Luchini, F Bibeau, MJL Ligtenberg, N Singh, A Nottegar, T Bosse, ... Annals of Oncology 30 (8), 1232-1243, 2019 | 876 | 2019 |
| Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis M Chilosi, V Poletti, A Zamò, M Lestani, L Montagna, P Piccoli, S Pedron, ... The American journal of pathology 162 (5), 1495-1502, 2003 | 826 | 2003 |
| Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors G Zamboni, A Scarpa, G Bogina, C Iacono, C Bassi, G Talamini, F Sessa, ... The American journal of surgical pathology 23 (4), 410-422, 1999 | 813 | 1999 |
| Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ... Cancer discovery 7 (10), 1116-1135, 2017 | 781 | 2017 |
| Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas Y Jiao, TM Pawlik, RA Anders, FM Selaru, MM Streppel, DJ Lucas, ... Nature genetics 45 (12), 1470-1473, 2013 | 708 | 2013 |
| Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 679 | 2015 |
| Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway E Missiaglia, I Dalai, S Barbi, S Beghelli, M Falconi, M Della Peruta, ... Journal of clinical oncology 28 (2), 245-255, 2010 | 613 | 2010 |
| TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study G Rindi, M Falconi, C Klersy, L Albarello, L Boninsegna, MW Buchler, ... Journal of the National Cancer Institute 104 (10), 764-777, 2012 | 548 | 2012 |
| Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients A Scarpa, W Mantovani, P Capelli, S Beghelli, L Boninsegna, R Bettini, ... Modern Pathology 23 (6), 824-833, 2010 | 543 | 2010 |
| Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): sensitivity analysis of trials in … L Carbognin, S Pilotto, M Milella, V Vaccaro, M Brunelli, A Caliò, ... PloS one 10 (6), e0130142, 2015 | 534 | 2015 |
